MA56108A - Identification et sélection d'un précurseur de plante de sulfate de chondroïtine et d'acide hyaluronique de plante, et transformation dudit précurseur de plante pour obtenir des ingrédients destinés à être utilisés dans des aliments, des suppléments, des dispositifs médicaux ou dans des médicaments - Google Patents
Identification et sélection d'un précurseur de plante de sulfate de chondroïtine et d'acide hyaluronique de plante, et transformation dudit précurseur de plante pour obtenir des ingrédients destinés à être utilisés dans des aliments, des suppléments, des dispositifs médicaux ou dans des médicamentsInfo
- Publication number
- MA56108A MA56108A MA056108A MA56108A MA56108A MA 56108 A MA56108 A MA 56108A MA 056108 A MA056108 A MA 056108A MA 56108 A MA56108 A MA 56108A MA 56108 A MA56108 A MA 56108A
- Authority
- MA
- Morocco
- Prior art keywords
- plant
- precursor
- supplements
- foods
- drugs
- Prior art date
Links
- 239000002243 precursor Substances 0.000 title 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
- 229920001287 Chondroitin sulfate Polymers 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 235000013305 food Nutrition 0.000 title 1
- 229920002674 hyaluronan Polymers 0.000 title 1
- 229960003160 hyaluronic acid Drugs 0.000 title 1
- 239000004615 ingredient Substances 0.000 title 1
- 239000013589 supplement Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Materials Engineering (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Inorganic Chemistry (AREA)
- Sustainable Development (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102019000008409A IT201900008409A1 (it) | 2019-06-07 | 2019-06-07 | Individuazione e selezione di un materiale di partenza vegetale di condroitina solfato e acido ialuronico vegetali, e trasformazione di tale materiale di partenza vegetale per l’ottenimento di ingredienti per utilizzo in alimenti, integratori, dispositivi medici o farmaci |
Publications (1)
Publication Number | Publication Date |
---|---|
MA56108A true MA56108A (fr) | 2022-04-13 |
Family
ID=68281820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA056108A MA56108A (fr) | 2019-06-07 | 2020-06-08 | Identification et sélection d'un précurseur de plante de sulfate de chondroïtine et d'acide hyaluronique de plante, et transformation dudit précurseur de plante pour obtenir des ingrédients destinés à être utilisés dans des aliments, des suppléments, des dispositifs médicaux ou dans des médicaments |
Country Status (15)
Country | Link |
---|---|
US (1) | US20220304355A1 (fr) |
EP (1) | EP3980030A2 (fr) |
JP (1) | JP2022535453A (fr) |
KR (1) | KR20220019275A (fr) |
CN (1) | CN114174349A (fr) |
AU (1) | AU2020287013A1 (fr) |
BR (1) | BR112021024063A2 (fr) |
CA (1) | CA3142672A1 (fr) |
EA (1) | EA202193158A1 (fr) |
IL (1) | IL288629A (fr) |
IT (1) | IT201900008409A1 (fr) |
MA (1) | MA56108A (fr) |
MX (1) | MX2021014736A (fr) |
WO (1) | WO2020245809A2 (fr) |
ZA (1) | ZA202109499B (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT202000013633A1 (it) * | 2020-06-08 | 2021-12-08 | Vivatis Pharma Gmbh | Processo di estrazione di una condroitina solfato da un fungo, una condroitina solfato di origine vegetale e suo uso |
AU2021286956A1 (en) * | 2020-06-08 | 2023-01-05 | Vivatis Pharma Gmbh | Process for extracting a hyaluronic acid from a fungus, a hyaluronic acid of plant origin and use thereof |
IT202000013618A1 (it) * | 2020-06-08 | 2021-12-08 | Vivatis Pharma Gmbh | Processo di estrazione di un acido ialuronico da un fungo, un acido ialuronico di origine vegetale e suo uso |
IT202000022471A1 (it) * | 2020-09-23 | 2022-03-23 | Sofar Swiss Sa | Composizioni comprendenti una condroitina vegetale o un suo analogo e loro uso nel trattamento disturbi della mucosa del tratto orale, faringo-laringeo e/o gastro-esofageo |
IT202200015375A1 (it) | 2022-07-21 | 2024-01-21 | Vivatis Pharma Italia S R L | Un nuovo acido ialuronico ad alto peso molecolare o un suo sale di origine vegetale per l’uso nel mantenere l'omeostasi articolare e prevenire i processi dannosi dell'osteoartrite |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1291394B1 (it) * | 1997-01-10 | 1999-01-11 | Innovet Italia | Composizioni ad attivita' condroprotettiva per il trattamento di artropatie traumatiche e/o cronico-degenerative. |
TWI398275B (zh) * | 2010-07-12 | 2013-06-11 | Agricultural Res Inst | 皮膚創傷敷料及其製備方法 |
RS53135B (en) * | 2011-11-24 | 2014-06-30 | Quimera Ingenieria Biomedica, S.L. | COMPLEX OBTAINED FROM HYALURONIC ACID OR ITS SALT AND MIXTURE OF HONDROITIN SULPHATE |
CN104140472B (zh) * | 2013-05-08 | 2017-11-28 | 清华大学 | 精品硫酸软骨素a和c和制备精品硫酸软骨素a和c的方法 |
EP3463304A4 (fr) * | 2016-05-24 | 2020-01-08 | Bol Pharma Ltd. | Compositions comprenant du cannabidiol et de l'acide hyaluronique pour le traitement de maladies inflammatoires des articulations |
CN105950688A (zh) * | 2016-06-25 | 2016-09-21 | 仇颖超 | 一种以银耳子实体制备植物基透明质酸的方法 |
CN106074214A (zh) * | 2016-07-13 | 2016-11-09 | 袁春华 | 一种抗辐射防衰老面膜的制备方法 |
IT201600101413A1 (it) * | 2016-10-10 | 2018-04-10 | Sofar Swiss S A | Composizione liquida per uso nel trattamento del reflusso gastroesofageo |
CN106905440B (zh) * | 2017-04-14 | 2019-03-19 | 中国林业科学研究院林产化学工业研究所 | 一种银耳多糖提取的方法 |
CN107522782A (zh) * | 2017-09-26 | 2017-12-29 | 天津市天大天福生物技术有限公司 | 一种梯度胶原蛋白及胶原多肽分子的制备方法及其应用 |
IT201700124434A1 (it) * | 2017-10-31 | 2019-05-01 | Sofar Swiss Sa | Compressa da succhiare e/o sciogliere in bocca a base di acido ialuronico e condroitina solfato e loro sali per uso nel trattamento di una sottopopolazione di pazienti GERD. |
CN109430650A (zh) * | 2018-11-22 | 2019-03-08 | 天津市天大天福生物技术有限公司 | 制备胶原蛋白、透明质酸饮料和滋补液的配方与生产工艺 |
-
2019
- 2019-06-07 IT IT102019000008409A patent/IT201900008409A1/it unknown
-
2020
- 2020-06-08 WO PCT/IB2020/055362 patent/WO2020245809A2/fr unknown
- 2020-06-08 JP JP2021572562A patent/JP2022535453A/ja active Pending
- 2020-06-08 CA CA3142672A patent/CA3142672A1/fr active Pending
- 2020-06-08 AU AU2020287013A patent/AU2020287013A1/en active Pending
- 2020-06-08 EP EP20736429.0A patent/EP3980030A2/fr active Pending
- 2020-06-08 MX MX2021014736A patent/MX2021014736A/es unknown
- 2020-06-08 BR BR112021024063A patent/BR112021024063A2/pt unknown
- 2020-06-08 KR KR1020227000680A patent/KR20220019275A/ko unknown
- 2020-06-08 MA MA056108A patent/MA56108A/fr unknown
- 2020-06-08 CN CN202080041088.5A patent/CN114174349A/zh active Pending
- 2020-06-08 US US17/616,960 patent/US20220304355A1/en active Pending
- 2020-06-08 EA EA202193158A patent/EA202193158A1/ru unknown
-
2021
- 2021-11-24 ZA ZA2021/09499A patent/ZA202109499B/en unknown
- 2021-12-02 IL IL288629A patent/IL288629A/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2021014736A (es) | 2022-02-11 |
IT201900008409A1 (it) | 2020-12-07 |
AU2020287013A1 (en) | 2021-12-23 |
WO2020245809A3 (fr) | 2021-01-14 |
KR20220019275A (ko) | 2022-02-16 |
JP2022535453A (ja) | 2022-08-08 |
US20220304355A1 (en) | 2022-09-29 |
BR112021024063A2 (pt) | 2022-04-26 |
WO2020245809A2 (fr) | 2020-12-10 |
EP3980030A2 (fr) | 2022-04-13 |
IL288629A (en) | 2022-02-01 |
WO2020245809A4 (fr) | 2021-04-08 |
ZA202109499B (en) | 2024-05-30 |
EA202193158A1 (ru) | 2022-03-17 |
CA3142672A1 (fr) | 2020-12-10 |
CN114174349A (zh) | 2022-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA56108A (fr) | Identification et sélection d'un précurseur de plante de sulfate de chondroïtine et d'acide hyaluronique de plante, et transformation dudit précurseur de plante pour obtenir des ingrédients destinés à être utilisés dans des aliments, des suppléments, des dispositifs médicaux ou dans des médicaments | |
US20180000095A1 (en) | Microbicidal oil-in-water dispersion | |
BR112019006957A2 (pt) | uso de idhp na preparação de fármaco ou produto de saúde para a prevenção e tratamento de doença de aterosclerose coronária | |
US20220009882A1 (en) | Organosulfur compounds | |
CR20220620A (es) | Composición farmacéutica acuosa de levilimab y su uso | |
CN1647802A (zh) | 一种皮肤外用品 | |
CN1170528A (zh) | 一种藻制品 | |
CN217067144U (zh) | 一种病媒生物防制用药剂喷洒装置 | |
Vons et al. | Comparative study of markets of Ukraine, Poland and Russia on registered medications for local treatment of burns | |
CN103893665B (zh) | 一种提高鸡产蛋量的中药组合物 | |
Tikhonov et al. | Problem aspects of the new technologies ophthalmic drugs | |
Кузякова et al. | THE MAIN TRENDS IN THE DEVELOPMENT OF THE PHARMACEUTICAL MARKET | |
Shpychak et al. | Marketing research of the pharmaceutical market of medicines used topically for diseases of the locomotor apparatus | |
Seryogin et al. | About illness of foodborne diseases | |
Matiacevich | Development of bioactive/active additives based on essential oils: A review | |
Pinkevych et al. | Lichens are sources of biological active compounds | |
JP6749563B2 (ja) | 黄色ブドウ球菌抑制溶液、アトピー性皮膚炎治療液、化粧品、洗浄液及び消毒液 | |
CN106606632A (zh) | 一种嘴唇干裂抑菌护理膏 | |
Кунанбай et al. | Modern principles of pharmacotherapy in Neonatology | |
CN109833388A (zh) | 一种口腔溃疡灵 | |
CN102283825A (zh) | 一种具有广普杀菌的药物 | |
Lisovska et al. | The relevance of creating a homeopathic anti-inflammatory drug | |
MacDonald | Medicinal Plants and Tomorrow’s Pharmacy–Nigerian Experience | |
CLEANSERS | hexachlorophene (C) dispense 5 ml into wet hand, work up into lather; then apply to area to be cleansed; rinse thoroughly pHisoHex Liq clnsr: 5, 16 oz | |
CN1923267A (zh) | 一种妇科外用抗菌药物及其制备方法 |